Colin R. Dormuth

Bio

Dr. Colin Dormuth joined the Faculty of Medicine at the University of British Columbia in 2007. He is currently an Associate Professor in the Department of Anesthesiology, Pharmacology & Therapeutics and Co-Director of the Therapeutics Initiative at UBC. Previously, he served as Chair for the Pharmacoepidemiology Group at the Therapeutics Initiative (2006 to 2019). Dr. Dormuth has also been co-principal investigator for the British Columbia site of the Canadian Network for Observational Drug Effect Studies (DSEN-CNODES) since 2011.  Within CNODES, he has participated as the BC Site Liason for multiple studies, served as Project Lead on the CNODES Training Team, and has been an active participant in the CNODES Methods Team.

Dr. Dormuth has over 20 years of experience using administrative health care databases to evaluate drug safety, pharmaceutical policy changes and physician prescribing behaviour. He has training in epidemiology, economic theory, applied econometrics, health services outcome research, and biostatistics. Dr. Dormuth holds Sc.D. and S.M. degrees in epidemiology from Harvard University, an M.A. in economics from the University of Victoria, and a B.A. in economics from the University of Manitoba.

As Principal Investigator or Co-Principal Investigator, Dr. Dormuth has been awarded over $47 million in research funding from the Canadian Institutes for Health Research (CIHR), of which more than $40 million has been awarded since 2011, including the Canadian Network for Observational Drug Effect Studies (CNODES).

CNODES Projects